| Primary |
| Drug Use For Unknown Indication |
32.9% |
| Urinary Tract Infection |
9.8% |
| Sinusitis |
7.3% |
| Pneumonia |
6.1% |
| Suicide Attempt |
6.1% |
| Infectious Mononucleosis |
3.7% |
| Pharyngitis |
3.7% |
| Tonsillitis |
3.7% |
| Acute Tonsillitis |
2.4% |
| Bronchitis |
2.4% |
| Depression |
2.4% |
| Hypertension |
2.4% |
| Insomnia |
2.4% |
| Lymphangitis |
2.4% |
| Menopause |
2.4% |
| Nasopharyngitis |
2.4% |
| Self-medication |
2.4% |
| Viral Infection |
2.4% |
| Bacterial Infection |
1.2% |
| Blood Pressure |
1.2% |
|
| Urticaria |
27.8% |
| Vomiting |
14.8% |
| Purpura |
5.6% |
| Pyrexia |
5.6% |
| Synovitis |
5.6% |
| Convulsion |
3.7% |
| Diarrhoea Haemorrhagic |
3.7% |
| Febrile Convulsion |
3.7% |
| Oedema |
3.7% |
| Phlebitis |
3.7% |
| Pneumonia |
3.7% |
| Rash Maculo-papular |
3.7% |
| Anaphylactic Shock |
1.9% |
| Cardiac Arrest |
1.9% |
| Delirium |
1.9% |
| Diarrhoea |
1.9% |
| Drug Administration Error |
1.9% |
| Haemorrhage |
1.9% |
| Hypertension |
1.9% |
| Intentional Overdose |
1.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
45.8% |
| Product Used For Unknown Indication |
12.5% |
| Pulmonary Tuberculosis |
5.2% |
| Oropharyngeal Pain |
4.2% |
| Gastritis |
3.1% |
| Hypertension |
3.1% |
| Juvenile Idiopathic Arthritis |
3.1% |
| Apical Granuloma |
2.1% |
| Bronchopneumopathy |
2.1% |
| Convulsion |
2.1% |
| Intubation |
2.1% |
| Postoperative Analgesia |
2.1% |
| Postoperative Care |
2.1% |
| Sedation |
2.1% |
| Supplementation Therapy |
2.1% |
| Vitamin Supplementation |
2.1% |
| Antibiotic Prophylaxis |
1.0% |
| Antiinflammatory Therapy |
1.0% |
| Aspiration |
1.0% |
| Glaucoma |
1.0% |
|
| Toxic Skin Eruption |
13.3% |
| Vomiting |
13.3% |
| Diarrhoea |
6.7% |
| Laryngeal Oedema |
6.7% |
| Leukocytosis |
6.7% |
| Leukopenia |
6.7% |
| Otitis Externa |
6.7% |
| Prothrombin Time Ratio Decreased |
6.7% |
| Pruritus |
6.7% |
| Sinusitis |
6.7% |
| Urticaria |
6.7% |
| Vision Blurred |
6.7% |
| Wound Evisceration |
6.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.5% |
| Product Used For Unknown Indication |
12.4% |
| Osteitis |
9.5% |
| Diffuse Large B-cell Lymphoma |
6.9% |
| Diabetes Mellitus |
5.3% |
| Pain |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Hiv Infection |
3.8% |
| Pyrexia |
3.3% |
| Pain In Extremity |
2.4% |
| Hypercholesterolaemia |
2.1% |
| Constipation |
1.9% |
| Hypertension |
1.9% |
| Non-hodgkin's Lymphoma |
1.7% |
| Pharyngolaryngeal Pain |
1.7% |
| Bronchitis |
1.4% |
| Urinary Tract Infection |
1.4% |
| Antibiotic Prophylaxis |
1.2% |
| Pneumonia |
1.2% |
| Prophylaxis |
1.2% |
|
| Osteitis |
18.9% |
| White Blood Cell Count Decreased |
11.3% |
| Urinary Tract Infection |
7.5% |
| Vomiting |
7.5% |
| Renal Failure Acute |
5.7% |
| Shock |
5.7% |
| Stevens-johnson Syndrome |
5.7% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Oedema Peripheral |
3.8% |
| Pruritus |
3.8% |
| Pulmonary Oedema |
3.8% |
| Renal Impairment |
3.8% |
| Retinal Haemorrhage |
3.8% |
| Wheezing |
3.8% |
| Budd-chiari Syndrome |
1.9% |
| Drug Interaction |
1.9% |
| Escherichia Infection |
1.9% |
| Extravasation |
1.9% |
| Fistula |
1.9% |
| Haematoma |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Atrial Fibrillation |
25.0% |
| Bronchopneumonia |
25.0% |
|
| Haematoma |
50.0% |
| Hypersensitivity |
50.0% |
|
